164 related articles for article (PubMed ID: 3871433)
21. Hodgkin's disease-derived cell lines--conflicting clues for the origin of Hodgkin's disease?
Drexler HG; Amlot PL; Minowada J
Leukemia; 1987 Sep; 1(9):629-37. PubMed ID: 3312848
[TBL] [Abstract][Full Text] [Related]
22. Lymphocyte functional antigens stabilize agglutination between Reed-Sternberg cells and T cells, but are not responsible for homotypic binding of Hodgkin's Reed-Sternberg cells.
Hsu SM; Hsu PL
Am J Pathol; 1990 Sep; 137(3):563-74. PubMed ID: 1698024
[TBL] [Abstract][Full Text] [Related]
23. Identification of Hodgkin and Sternberg-reed cells as a unique cell type derived from a newly-detected small-cell population.
Stein H; Gerdes J; Schwab U; Lemke H; Mason DY; Ziegler A; Schienle W; Diehl V
Int J Cancer; 1982 Oct; 30(4):445-59. PubMed ID: 6754630
[TBL] [Abstract][Full Text] [Related]
24. Expression of B-cell antigens by Hodgkin's and Reed-Sternberg cells.
Schmid C; Pan L; Diss T; Isaacson PG
Am J Pathol; 1991 Oct; 139(4):701-7. PubMed ID: 1656757
[TBL] [Abstract][Full Text] [Related]
25. The Reed-Sternberg cell/lymphocyte rosette. I. Properties of rosettes formed between Hodgkin's cell lines and allogeneic lymphocytes.
Flavell DJ; Wright DH
Br J Cancer; 1989 Feb; 59(2):165-73. PubMed ID: 2495015
[TBL] [Abstract][Full Text] [Related]
26. The immunopathology of Hodgkin's disease.
Long JC
Clin Haematol; 1979 Oct; 8(3):531-66. PubMed ID: 159150
[TBL] [Abstract][Full Text] [Related]
27. Phenotypic and genotypic analysis of Hodgkin's disease derived cell lines: histopathological and clinical implications.
Diehl V; Pfreundschuh M; Fonatsch C; Stein H; Falk M; Burrichter H; Schaadt M
Cancer Surv; 1985; 4(2):399-419. PubMed ID: 3842319
[TBL] [Abstract][Full Text] [Related]
28. Abnormalities of in vitro immunoglobulin synthesis by peripheral blood lymphocytes from untreated patients with Hodgkin's disease.
Romagnani S; Del Prete GF; Maggi E; Bellesi G; Biti G; Rossi Ferrini PL; Ricci M
J Clin Invest; 1983 May; 71(5):1375-82. PubMed ID: 6602150
[TBL] [Abstract][Full Text] [Related]
29. Anti-Leu-3a antibody reactivity with Reed-Sternberg cells of Hodgkin's disease.
Oka K; Mori N; Kojima M
Arch Pathol Lab Med; 1988 Feb; 112(2):139-42. PubMed ID: 3257383
[TBL] [Abstract][Full Text] [Related]
30. Expression and signal transduction of T-cell antigen receptor (TCR)/CD3 complexes on fresh or in vitro expanded T lymphocytes from patients with Hodgkin's and non-Hodgkin's lymphomas.
Rubin B; Martin EP; Arnaud J; Delsol G; Plesner T; Ratsimbazafy A; Llobera R; Holm B; Mariame B
Scand J Immunol; 1997 Jun; 45(6):715-25. PubMed ID: 9201313
[TBL] [Abstract][Full Text] [Related]
31. BLA.36: a glycoprotein specifically expressed on the surface of Hodgkin's and B cells.
Imam A; Stathopoulos E; Taylor CR
Anticancer Res; 1990; 10(4):1095-104. PubMed ID: 1696446
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemical analysis of the distribution of lymphocyte subpopulations in Hodgkin's disease.
Borowitz MJ; Croker BP; Metzgar RS
Cancer Treat Rep; 1982 Apr; 66(4):667-74. PubMed ID: 6210433
[TBL] [Abstract][Full Text] [Related]
33. Reed-Sternberg/lymphocyte rosette: lymphocyte subpopulations as defined by monoclonal antibodies.
Morris CS; Stuart AE
J Clin Pathol; 1984 Jul; 37(7):767-71. PubMed ID: 6378976
[TBL] [Abstract][Full Text] [Related]
34. Phenotypic expression of Hodgkin's and Reed-Sternberg cells in Hodgkin's disease.
Hsu SM; Yang K; Jaffe ES
Am J Pathol; 1985 Feb; 118(2):209-17. PubMed ID: 3970138
[TBL] [Abstract][Full Text] [Related]
35. Morphologically normal, CD30-negative B-lymphocytes with chromosome aberrations in classical Hodgkin's disease: the progenitor cell of the malignant clone?
Jansen MP; Hopman AH; Bot FJ; Haesevoets A; Stevens-Kroef MJ; Arends JW; Jox A; Wolf J; Ramaekers FC; Schouten HC
J Pathol; 1999 Dec; 189(4):527-32. PubMed ID: 10629553
[TBL] [Abstract][Full Text] [Related]
36. "Sternberg-reed" giant cells of Hodgkin's Disease: cultivation in vitro, heterotransplantation, and characterization as neoplastic macrophages.
Kaplan HS; Gartner S
Int J Cancer; 1977 Apr; 19(4):511-25. PubMed ID: 844918
[TBL] [Abstract][Full Text] [Related]
37. Tissue culture studies in Hodgkin's disease: Morphologic, cytogenetic, cell surface, and enzymatic properties of cultures derived from splenic tumors.
Long JC; Zamecnik PC; Aisenberg AC; Atkins L
J Exp Med; 1977 Jun; 145(6):1484-500. PubMed ID: 68093
[TBL] [Abstract][Full Text] [Related]
38. Granzyme B expression in Reed-Sternberg cells of Hodgkin's disease.
Oudejans JJ; Kummer JA; Jiwa M; van der Valk P; Ossenkoppele GJ; Kluin PM; Kluin-Nelemans JC; Meijer CJ
Am J Pathol; 1996 Jan; 148(1):233-40. PubMed ID: 8546210
[TBL] [Abstract][Full Text] [Related]
39. Aberrant expression of T cell and B cell markers in myelocyte/monocyte/histiocyte-derived lymphoma and leukemia cells. Is the infrequent expression of T/B cell markers sufficient to establish a lymphoid origin for Hodgkin's Reed-Sternberg cells?
Hsu SM; Hsu PL
Am J Pathol; 1989 Jan; 134(1):203-12. PubMed ID: 2492402
[TBL] [Abstract][Full Text] [Related]
40. The origins of Hodgkin's disease.
Michels KB
Eur J Cancer Prev; 1995 Oct; 4(5):379-88. PubMed ID: 7496327
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]